Lunai Bioworks (LNAI) Shareholder's Equity (2011 - 2026)

Lunai Bioworks (LNAI) Shareholder's Equity (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Lunai Bioworks 95.85 Mn 92.70 Mn 20,942.00 -9.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.55 Mn
Dec 31, 2025 -13.55 Mn
Sep 30, 2025 -13.04 Mn
Jun 30, 2025 -21.35 Mn
Mar 31, 2025 88.39 Mn
Dec 31, 2024 82.06 Mn
Sep 30, 2024 98.09 Mn
Jun 30, 2024 131.98 Mn
Mar 31, 2024 134.41 Mn
Dec 31, 2023 43.60 Mn
Sep 30, 2023 46.75 Mn
Jun 30, 2023 46.50 Mn
Mar 31, 2023 66.13 Mn
Dec 31, 2022 66.90 Mn
Sep 30, 2022 70.32 Mn
Jun 30, 2022 72.62 Mn
Mar 31, 2022 161.24 Mn
Dec 31, 2021 165.62 Mn
Sep 30, 2021 166.97 Mn
Jun 30, 2021 174.66 Mn